Perbedaan Morenzo Abadi Perkasa Tbk. dan Merck Tbk.: Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp68 (kapitalisasi pasar 149,22 M, volume 24 jam 1,55 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.850 (kapitalisasi pasar 1,7 T, volume 24 jam 21,9 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 11,4× kapitalisasi pasar Morenzo Abadi Perkasa Tbk., dan Morenzo Abadi Perkasa Tbk. lebih aktif diperdagangkan (1,55 jt vs 21,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ENZO | MERK | |
|---|---|---|
Kapitalisasi Pasar | 149,22 M | 1,7 T |
Volume | 1,55 jt | 21,9 rb |
Lot | 15,46 rb | 219 |
Perputaran | 105,26 jt | 83,99 jt |
Harga Rata-rata | 68,07 | 3.834,93 |
Nilai Transaksi | 105,26 jt | 83,99 jt |
Harga Ekuilibrium Indikatif | 69 | 3.850 |
Volume Ekuilibrium Indikatif | 66 rb | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Selengkapnya di halaman ENZO →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →